These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28531906)

  • 1. Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease.
    Zuelgaray E; Domont F; Peiffer-Smadja N; Saadoun D; Cacoub P
    Ann Intern Med; 2017 Jul; 167(2):141-142. PubMed ID: 28531906
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of tocilizumab in refractory adult-onset Still's disease; report of 2 cases.
    Andrade-Ortega L; Irazoque-Palazuelos F; Muñoz-López S; Rosales-Don Pablo VM
    Reumatol Clin; 2014; 10(3):199-200. PubMed ID: 24076178
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
    Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD).
    Yoshimura M; Makiyama J; Koga T; Miyashita T; Izumi Y; Torigoshi T; Motokawa S; Eguchi K; Migita K
    Clin Exp Rheumatol; 2010; 28(1):141-2. PubMed ID: 20346255
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tocilizumab effectiveness in adult Still's disease].
    López Buitrago R; Estrada Dorronsoro S; Cervera Segura R; Espinosa Garriga G
    Med Clin (Barc); 2012 Jan; 138(1):42-3. PubMed ID: 21605875
    [No Abstract]   [Full Text] [Related]  

  • 6. [Successful tocilizumab therapy for adult onset Still's disease with intractable conditions over ten years].
    Takahashi Y; Ochi H; Yanai A; Yamashita H; Itoh K; Mimori A
    Nihon Naika Gakkai Zasshi; 2010 Jan; 99(1):130-2. PubMed ID: 20196484
    [No Abstract]   [Full Text] [Related]  

  • 7. Tocilizumab for multirefractory adult-onset Still's disease.
    De Bandt M; Saint-Marcoux B
    Ann Rheum Dis; 2009 Jan; 68(1):153-4. PubMed ID: 19088261
    [No Abstract]   [Full Text] [Related]  

  • 8. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
    Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
    Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful slow tocilizumab desensitization in a patient with adult onset Still disease.
    Erdogan T; Yasar Bilge NS; Kasifoglu T
    Biologicals; 2018 Sep; 55():17-18. PubMed ID: 30017556
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antagonists of interleukin-6 (tocilizumab), in adult refractory still disease].
    Sekkach Y; Elqatni M; Khattabi AE; Fatihi J; Hammi S; Badaoui M; Elomri N; Mekouar F; Amezyane T; Abouzahir A; Ghafir D
    Presse Med; 2011; 40(7-8):e333-7. PubMed ID: 21550202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
    Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
    Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years.
    Nakahara H; Mima T; Yoshio-Hoshino N; Matsushita M; Hashimoto J; Nishimoto N
    Mod Rheumatol; 2009; 19(1):69-72. PubMed ID: 18762861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA nephropathy in adult-onset Still's disease after tocilizumab treatment: a case report.
    Kang JH
    Int Urol Nephrol; 2022 May; 54(5):1167-1168. PubMed ID: 34269969
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab.
    Yamada H; Kaneko Y; Tamai H; Takeuchi T
    Rheumatology (Oxford); 2020 Feb; 59(2):440-442. PubMed ID: 31504968
    [No Abstract]   [Full Text] [Related]  

  • 15. Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum.
    Saito J; Yakuwa N; Kaneko K; Takai C; Goto M; Nakajima K; Yamatani A; Murashima A
    Rheumatology (Oxford); 2019 Aug; 58(8):1505-1507. PubMed ID: 30945743
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adult onset Still's disease with small vessel vasculitis].
    Hoff P; Hoyer BF; Schneider U; Kneitz C; Burmester GR; Buttgereit F
    Z Rheumatol; 2015 Aug; 74(6):540-2. PubMed ID: 26231832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab in adult-onset Still's disease: the Israeli experience.
    Elkayam O; Jiries N; Dranitzki Z; Kivity S; Lidar M; Levy O; Ablin J; Abu-Shakra M; Savargyl-Maman H; Padova H; Caspi D; Rosner I
    J Rheumatol; 2014 Feb; 41(2):244-7. PubMed ID: 24429168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Low-Dose Tocilizumab on Relapsing Adult-Onset Still's Disease.
    Vandemergel X; Vandergheynst F
    Acta Medica (Hradec Kralove); 2016; 59(1):22-5. PubMed ID: 27131353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
    Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
    Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adult refractory Still disease with atypical articular manifestations: efficacity of interleukin-6 antagonists (tocilizumab)].
    Rkiouak A; Ennibi K; Zinebi A; Akhouad Y; Reggad A; Rabhi M; Chaari J
    Ann Pharm Fr; 2012 May; 70(3):163-8. PubMed ID: 22655584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.